IL6 and COVID-19: From these data, it can be postulated that in COVID-19 patients increased levels of aldosterone [11] activate the NF-κB signaling pathway via the MR [26, 27], which activates the expression of pro-inflammatory cytokines such as TNFα and IL-6 [26].